Price
$4.49
Decreased by -2.60%
Dollar volume (20D)
915.11 K
ADR%
11.08
Shares float
2.14 B
Shares short
197.28 K [0.01%]
Shares outstanding
3.72 M
Market cap
17.15 M
Beta
0.90
Price/earnings
N/A
20D range
3.79 6.59
50D range
2.87 7.77
200D range
2.30 26.80

BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.

The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma.

It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions.

BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 27, 25 -1.50
Decreased by -900.40%
-1.06
Decreased by -41.57%
Nov 4, 24 -0.07
Decreased by -628.00%
-0.10
Increased by +27.20%
Aug 15, 24 0.01
Increased by +102.03%
-0.14
Increased by +104.36%
May 28, 24 -0.01
Increased by +93.33%
-0.29
Increased by +96.55%
Mar 28, 24 -0.15
Decreased by -66.67%
-0.16
Increased by +6.25%
Nov 20, 23 -0.01
Increased by 0.00%
-0.21
Increased by +95.24%
Aug 30, 23 -0.30
Decreased by -100.00%
-0.11
Decreased by -172.73%
May 25, 23 -0.15
Increased by 0.00%
-0.17
Increased by +11.76%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 255.00 K
Decreased by -96.28%
5.13 M
Increased by +836.64%
Increased by +2.01 K%
Increased by +19.90 K%
Dec 31, 24 11.75 M
Increased by +144.77%
-3.19 M
Increased by +77.05%
Decreased by -27.13%
Increased by +90.62%
Sep 30, 24 4.94 M
Increased by +N/A%
-5.82 M
Increased by +63.66%
Decreased by -117.78%
Decreased by N/A%
Jun 30, 24 5.39 M
Increased by +N/A%
484.00 K
Increased by +102.61%
Increased by +8.97%
Decreased by N/A%
Mar 31, 24 6.86 M
Increased by +N/A%
-696.00 K
Increased by +95.50%
Decreased by -10.15%
Decreased by N/A%
Dec 31, 23 4.80 M
Increased by +N/A%
-13.88 M
Decreased by -353.13%
Decreased by -289.25%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-16.02 M
Decreased by -142.19%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-18.55 M
Decreased by -154.60%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY